332 related articles for article (PubMed ID: 22707362)
1. Impact of excipient interactions on solid dosage form stability.
Narang AS; Desai D; Badawy S
Pharm Res; 2012 Oct; 29(10):2660-83. PubMed ID: 22707362
[TBL] [Abstract][Full Text] [Related]
2. Excipient Stability in Oral Solid Dosage Forms: A Review.
Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
[TBL] [Abstract][Full Text] [Related]
3. Impact of excipient interactions on drug bioavailability from solid dosage forms.
Panakanti R; Narang AS
Pharm Res; 2012 Oct; 29(10):2639-59. PubMed ID: 22610283
[TBL] [Abstract][Full Text] [Related]
4. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques.
Chadha R; Bhandari S
J Pharm Biomed Anal; 2014 Jan; 87():82-97. PubMed ID: 23845418
[TBL] [Abstract][Full Text] [Related]
5. A new approach to accelerated drug-excipient compatibility testing.
Sims JL; Carreira JA; Carrier DJ; Crabtree SR; Easton L; Hancock SA; Simcox CE
Pharm Dev Technol; 2003; 8(2):119-26. PubMed ID: 12760562
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of microwave oven heating for prediction of drug-excipient compatibilities and accelerated stability studies.
Schou-Pedersen AM; Østergaard J; Cornett C; Hansen SH
Int J Pharm; 2015 May; 485(1-2):97-107. PubMed ID: 25746946
[TBL] [Abstract][Full Text] [Related]
7. Role of water in the physical stability of solid dosage formulations.
Airaksinen S; Karjalainen M; Shevchenko A; Westermarck S; Leppänen E; Rantanen J; Yliruusi J
J Pharm Sci; 2005 Oct; 94(10):2147-65. PubMed ID: 16136577
[TBL] [Abstract][Full Text] [Related]
8. Selection of solid dosage form composition through drug-excipient compatibility testing.
Serajuddin AT; Thakur AB; Ghoshal RN; Fakes MG; Ranadive SA; Morris KR; Varia SA
J Pharm Sci; 1999 Jul; 88(7):696-704. PubMed ID: 10393567
[TBL] [Abstract][Full Text] [Related]
9. Biopharmaceutical aspects and implications of excipient variability in drug product performance.
Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182
[TBL] [Abstract][Full Text] [Related]
10. Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility.
Wu Y; Levons J; Narang AS; Raghavan K; Rao VM
AAPS PharmSciTech; 2011 Dec; 12(4):1248-63. PubMed ID: 21948318
[TBL] [Abstract][Full Text] [Related]
11. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form.
Wu Y; Dali M; Gupta A; Raghavan K
Pharm Dev Technol; 2009; 14(5):556-64. PubMed ID: 19743950
[TBL] [Abstract][Full Text] [Related]
12. Impact Of Excipient Variability On Drug Product Processing And Performance.
Peng Soh JL; Liew CV; Sia Heng PW
Curr Pharm Des; 2015; 21(40):5890-9. PubMed ID: 26446469
[TBL] [Abstract][Full Text] [Related]
13. Excipient variability and its impact on dosage form functionality.
Dave VS; Saoji SD; Raut NA; Haware RV
J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
[TBL] [Abstract][Full Text] [Related]
14. Stability of pharmaceutical salts in solid oral dosage forms.
Nie H; Byrn SR; Zhou QT
Drug Dev Ind Pharm; 2017 Aug; 43(8):1215-1228. PubMed ID: 28276282
[TBL] [Abstract][Full Text] [Related]
15. Microenvironmental pH modulation in solid dosage forms.
Badawy SI; Hussain MA
J Pharm Sci; 2007 May; 96(5):948-59. PubMed ID: 17455349
[TBL] [Abstract][Full Text] [Related]
16. Miniaturized approach for excipient selection during the development of oral solid dosage form.
Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
[TBL] [Abstract][Full Text] [Related]
17. Drug-Excipient Interactions in the Solid State: The Role of Different Stress Factors.
Gressl C; Brunsteiner M; Davis A; Landis M; Pencheva K; Scrivens G; Sluggett GW; Wood GPF; Gruber-Woelfler H; Khinast JG; Paudel A
Mol Pharm; 2017 Dec; 14(12):4560-4571. PubMed ID: 29058913
[TBL] [Abstract][Full Text] [Related]
18. Drug-excipient compatibility testing using a high-throughput approach and statistical design.
Wyttenbach N; Birringer C; Alsenz J; Kuentz M
Pharm Dev Technol; 2005; 10(4):499-505. PubMed ID: 16370179
[TBL] [Abstract][Full Text] [Related]
19. Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties. Case Study: Superdisintegrants.
Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
AAPS J; 2020 Feb; 22(2):46. PubMed ID: 32048079
[TBL] [Abstract][Full Text] [Related]
20. Ensuring Product Stability - Choosing the Right Excipients.
Veronica N; Heng PWS; Liew CV
J Pharm Sci; 2022 Aug; 111(8):2158-2171. PubMed ID: 35526577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
